CME Supplements

Managing Bipolar Depression: An Evidence-Based Approach

This activity is jointly sponsored/co-provided by Global Medical Education, HealthmattersCME, and Postgraduate Institute for Medicine. This activity is supported by an independent educational grant from Sunovion Pharmaceuticals.

 

Bipolar disorder is characterized by the cyclical occurrence of elevated (manic or hypomanic) and depressed mood states. The illness, which includes the bipolar I and bipolar II subtypes, exacts a heavy toll in terms of quality of life, functioning, morbidity, comorbidity, and mortality.1 Depressive episodes and symptoms deserve particular attention: Not only do they dominate the long-term course of the illness; they are associated with similar or greater psychosocial impairment than corresponding levels of manic or hypomanic symptoms.1

Recommended Reading

Estate planning
MDedge Psychiatry
Two studies document a rise in gun wounds, homicides
MDedge Psychiatry
The Navy Yard shooting and mental illness
MDedge Psychiatry
Recovering from trauma-informed care
MDedge Psychiatry
FDA to regulate few medical apps
MDedge Psychiatry
Did the authors slip on SOAPP?
MDedge Psychiatry
Online tool calculates Medicare incentives, penalties
MDedge Psychiatry
Cranial radiotherapy for acute lymphoblastic leukemia linked to impaired neurocognition
MDedge Psychiatry
Are doctors ‘gaming’ the incentive programs? CMS wants to know
MDedge Psychiatry
Tailored therapy needed to conquer IPV
MDedge Psychiatry